Ask AI
ProCE Banner Activity

Interactive Tool for the Frontline Treatment of CLL: An International Expert Perspective

Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with CLL with those of 5 renowned international experts.

Released: October 20, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Disclosure

Primary Author

Toby A. Eyre, MBChB, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, Autolus, BeOne Medicines, Bristol Myers Squibb, Galapagos, Janssen, Incyte, Lilly, Nurix, Roche.

Arnon P. Kater, MD, MPH: consultant/advisor/speaker: AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Genmab, Janssen, Roche/Genentech.

Vincent Ribrag, MD: researcher: Astex, GSK; consultant/advisor/speaker: AbbVie, AstraZeneca, BeiGene, Ipsen, Lilly; employee: Pegascy.

Stephan Stilgenbauer, MD: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, BeiGene, Bristol Myers Squibb, Galapagos, Gilead, GSK, Hoffmann-La Roche, Johnson & Johnson.

Alessandra Tedeschi, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeOne, Johnson & Johnson, Lilly.